Bristol Myers Squibb (BMY) Payables (2009 - 2026)
Bristol Myers Squibb (BMY) reported Payables of $4.63 billion for Q3 2026, up 7.9% from $4.29 billion a year earlier and up 11.3% from the prior quarter.
Bristol Myers Squibb (BMY) Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb posted Payables of $3.58 billion, down 0.7% from FY2024.
- Payables has a five-year compound annual growth rate of 5.7% (FY2020 to FY2025).
- By year, Payables came in at $3.6 billion in FY2024 (+10.5%), $3.26 billion in FY2023 (+7.2%), $3.04 billion in FY2022 (+3.1%) and $2.95 billion in FY2021 (+8.7%).
- The Q3 2026 figure ranks as the highest quarterly Payables since Q2 2025.
- Year over year, Payables gained in six of the last eight quarters, with growth averaging 10.2%.
- The high point for year-over-year Payables in five years was Q2 2025 (growth of 44.7%); the low point was Q2 2026 (a decline of 23.4%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $4.16 billion (Q2 2026), $4.23 billion (Q1 2026) and $3.58 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | -24.05 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn | 4.63 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.63 Bn |
| Jun 30, 2026 | 4.16 Bn |
| Mar 31, 2026 | 4.23 Bn |
| Dec 31, 2025 | 3.58 Bn |
| Sep 30, 2025 | 4.29 Bn |
| Jun 30, 2025 | 5.43 Bn |
| Mar 31, 2025 | 4.00 Bn |
| Dec 31, 2024 | 3.60 Bn |
| Sep 30, 2024 | 3.47 Bn |
| Jun 30, 2024 | 3.75 Bn |
| Mar 31, 2024 | 3.54 Bn |
| Dec 31, 2023 | 3.26 Bn |
| Sep 30, 2023 | 2.81 Bn |
| Jun 30, 2023 | 3.07 Bn |
| Mar 31, 2023 | 3.19 Bn |
| Dec 31, 2022 | 3.04 Bn |
| Sep 30, 2022 | 2.60 Bn |
| Jun 30, 2022 | 2.88 Bn |
| Mar 31, 2022 | 2.94 Bn |
| Dec 31, 2021 | 2.95 Bn |
Bristol Myers Squibb Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();